Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Circadin 2 mg in Insomnia Patients with Low Endogenous Melatonin
2006-004193-27Phase 3Completed
- Sponsor
- Neurim Pharmaceuticals
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Circadin 2 mg with Placebo (2 arms). Primary endpoint: Primary efficacy and safety outcomes. Started Feb 2008; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2006-004193-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004193-27.